Dimensional Fund Advisors LP Sells 1,064,002 Shares of CVS Health Corporation $CVS

Dimensional Fund Advisors LP reduced its holdings in shares of CVS Health Corporation (NYSE:CVS) by 12.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,369,261 shares of the pharmacy operator’s stock after selling 1,064,002 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.58% of CVS Health worth $555,577,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the business. SNS Financial Group LLC grew its stake in CVS Health by 2.5% in the 2nd quarter. SNS Financial Group LLC now owns 12,788 shares of the pharmacy operator’s stock valued at $882,000 after buying an additional 311 shares during the last quarter. Atlantic Union Bankshares Corp boosted its holdings in shares of CVS Health by 54.8% during the second quarter. Atlantic Union Bankshares Corp now owns 98,295 shares of the pharmacy operator’s stock worth $6,780,000 after acquiring an additional 34,804 shares during the period. Resona Asset Management Co. Ltd. grew its position in shares of CVS Health by 1.3% in the second quarter. Resona Asset Management Co. Ltd. now owns 461,922 shares of the pharmacy operator’s stock valued at $31,832,000 after purchasing an additional 5,714 shares during the last quarter. Golden State Wealth Management LLC increased its stake in shares of CVS Health by 318.6% during the second quarter. Golden State Wealth Management LLC now owns 1,218 shares of the pharmacy operator’s stock worth $84,000 after purchasing an additional 927 shares during the period. Finally, Achmea Investment Management B.V. lifted its holdings in CVS Health by 87.1% during the 2nd quarter. Achmea Investment Management B.V. now owns 244,724 shares of the pharmacy operator’s stock worth $16,881,000 after purchasing an additional 113,914 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. Piper Sandler restated an “overweight” rating and issued a $101.00 price target (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Mizuho lifted their price objective on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Robert W. Baird increased their target price on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Finally, JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.77.

CVS Health Price Performance

CVS Health stock opened at $80.57 on Thursday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. CVS Health Corporation has a 52 week low of $58.35 and a 52 week high of $85.15. The stock has a market capitalization of $102.50 billion, a P/E ratio of 58.38, a price-to-earnings-growth ratio of 0.84 and a beta of 0.49. The stock has a fifty day moving average of $78.53 and a 200-day moving average of $77.50.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is presently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.